Conference and Meeting Presentations
3/5/2022 Opexa Corporate Presentation Slides for The 6thth Annual CEO Life Science Forum Neil K. Warma, President & CEO.
2/11/2021 Opexa Corporate Presentation Slides for The 15th Annual BIO CEO & Investor Conference Neil K. Warma, President & CEO.
9/13/2012 Opexa Therapeutics, Inc. Corporate Presentation for the 8th Annual Burrill Personalized Medicine Meeting. Neil K. Warma, President & CEO.
9/13/2011 Opexa Therapeutics, Inc. Corporate Presentation for Rodman & Renshaw Annual Global Investment Conference - Healthcare. Neil K. Warma, President & CEO.
4/14/2011 Autologous T-Cell Immunotherapy (Tovaxin®) in Treatment-Naïve Patients with Active Relapsing-Remitting Multiple Sclerosis Clyde Markowitz, MD, Daniel Wynn, MD, FACN, FAASM, Edward J. Fox, MD, PhD, FAAN, Stanley Cohan, MD, PhD, Dawn McGuire, MD, FAAN
4/14/2010 Safety and Efficacy of Autologous T-Cell Immunotherapy (Tovaxin) in Patients with Active Relapsing-Remitting Multiple Sclerosis. McGuire, Dawn; Fox, Edward; Markowitz, Clyde; Cohan, Stanley; Wynn, Daniel; Rill, Donna; Inman, Shannon.
4/29/2009 American Academy of Neurology annual meeting. TERMS Trial T-Cell Vaccination Secondary Analysis of Clinical and Immunological Outcomes in Relapsing Remitting Multiple Sclerosis Patients. Fox, Edward; Markowitz, Clyde; Cohan, Stanley; Wynn, Daniel; Rill, Donna; Riser, Mary; Williams, Jim.
6/14/2008 International Society for Stem Cell Research. Ex vivo differentiation of adult human peripheral blood monocyte-derived cells into functional insulin-producing cells for the treatment of diabetes. Winnier, Glenn; Shannon, Michelle; Sciarrrota, Janice; Tilton, Ron; Newsom, Brian; Williams, Jim.
5/20/2008 International Society of Cell Therapy. Persistence of myelin reactive T-cells in relapsing-remitting Multiple Sclerosis patients receiving immunomodulatory treatment. Fox, Edward; Newsom, Brian; Montgomery, Mitzi; von-Gynz Rekowski, Kathrin; Riser, Mary; Inman, Shannon; Rill, Donna; Williams, Jim.
4/15/2008 American Academy of Neurology annual meeting. Autologous attenuated T cell vaccine (Tovaxin®) dose escalation in multiple sclerosis relapse-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. Loftus, Brian; Montgomery, Mitzi; Williams, Jim.
8/24/2007 Cambridge Healthtech Institute Summit on Targeted Immunotherapeutics and Vaccines Paving the Way for Autologous Cell Therapy for Autoimmunity. Williams, Jim.
6/24/2007 International Society for Cellular Therapy Diabetic patients’ monocyte derived insulin-producing islet-like clusters offer promise of autologous beta-cell replacement therapy for Type 1 and 2 diabetics. Winnier, Glenn; Sciarrrota, Janice; Shannon, Michelle; Newsom, Brian; Williams, Jim.
6/17/2007 International Society for Stem Cell Research. Reversal of hyperglycemia in diabetic NOD/SCID Mice by Subcapsular kidney transplantation of monocyte-derived insulin producing cells. Winnier, Glenn; Sciarrrota, Janice; Shannon, Michelle; Tilton, Ron; Newsom, Brian; Williams, Jim.
6/10/2021 Federation of Clinical Immunology Societies. Identifying New Immunodominant Myelin Peptides in Relapsing Remitting Multiple Sclerosis Patients. Newsom, Brian; VonGynz-Rekowski, Kathrin; Montgomery, Mitzi; Fox, Edward; Williams, Jim.
6/28/2006 International Society for Stem Cell Research. Differentiation of Monocyte-Derived Stem Cells into Pancreatic Islet-like Cells. Winnier, Glenn; Newsom, Brian; Rill, Donna; Williams, Jim.
6/29/2006 International Society for Stem Cell Research. The Identification and Characterization of Monocyte-Derived Stem Cells. Winnier, Glenn; Newsom, Brian; Rill, Donna; Williams, Jim.
6/5/2006. Federation of Clinical Immunology Societies. Characterization and Clinical Response of a T-Cell Vaccination for Multiple Sclerosis. Newsom, Brian; Winnier, Glenn; Montgomery, Mitzi; Rill, Donna; Williams, Jim.
5/5/2006. International Society for Cellular Therapy. A T-cell Vaccination for MS_Characterization and Clinical Response. Newsom, Brian; Winnier, Glenn; Rill, Donna; Williams, Jim.
5/5/2006. International Society for Cellular Therapy. The Identification and Characterization of Monocyte-Derived Stem Cells. Winnier, Glenn; Newsom, Brian; Rill, Donna; Williams, Jim.
5/5/2006. International Society for Cellular Therapy. Differentiation of Monocyte-Derived Stem Cells into Pancreatic Islet-like Cells. Winnier, Glenn; Newsom, Brian; Rill, Donna; Williams, Jim.
10/1/2005. 21st Congress of the European Committee/10th Annual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis. Autologous T cell Therapy in Multiple Sclerosis: An Open Laboratoryel Safety and Dose Range Study. Loftus, Brian; Montgomery, Mitzi, and Williams, Jim.